BMS Quote, Trading Chart, Bemis Company Inc.

$ Last:

0.00% Change Percent:

$N/A Open:

$57.25 Previous Close:

$N/A High:

$N/A Low:

0 Volume:

06/12/2019 09:32:17 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2019-06-12	N/A	57.25	N/A	N/A	0
2019-06-11	N/A	57.25	N/A	N/A	0
2019-06-10	58.10	57.25	58.88	57.11	9,399,975
2019-06-07	56.34	58.08	58.14	56.34	6,085,826
2019-06-06	56.20	56.10	56.98	55.85	22,108,643
2019-06-05	57.35	56.51	57.50	56.39	1,635,146
2019-06-04	57.50	57.20	58.48	56.26	9,494,455
2019-06-03	57.84	57.65	58.17	57.02	2,127,805
2019-05-31	57.63	58.35	58.44	57.53	837,625
2019-05-30	56.50	56.35	56.72	55.93	286,156
2019-05-29	56.90	56.54	56.90	56.23	316,980
2019-05-28	57.40	57.10	57.42	57.05	448,986
2019-05-27	57.26	57.40	57.5823	56.8931	163,124
2019-05-24	57.26	57.40	57.5823	56.8931	163,124
2019-05-23	57.33	57.25	57.49	56.92	323,062
2019-05-22	58.00	57.59	58.32	57.59	372,230
2019-05-21	58.11	58.12	58.265	57.96	580,783
2019-05-20	57.75	57.93	58.38	57.32	385,318
2019-05-17	57.64	58.00	58.33	57.40	372,152
2019-05-16	58.10	57.78	58.36	57.75	809,349

Stock Information

Bemis Company Inc. Company Name:

BMS Stock Symbol:

NYSE Market:

Get BMS Alerts

News, Short Squeeze, Breakout and More Instantly...

BMS - 2 of the Safest Dividend Stocks to Hold During a Market Crash

Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
BMS - Better Buy: bluebird bio vs. Exelixis

Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...
BMS - Better Buy: Crispr Therapeutics vs. bluebird bio

bluebird bio (NASDAQ: BLUE) is a biotech company that focuses on gene editing. This technology seeks to treat diseases by replacing the defective genes responsible for them with their healthy counterparts. Year to date, shares of Bluebird are down by 33.9%, which is significantly worse than ...